1 Farhat, T, Iannotti, RJ & Simons-Morton, BG (2010) Overweight, obesity, youth and health-risk behaviours. Am J Prev Med 38, 258–267.
2 Gentry, HC (1969) Origin of the common bean Phaseolus vulgaris. Econ Bot 23, 55–69.
3 Obiro, WC, Zhang, T & Jiang, B (2008) The nutraceutical role of Phaseolus vulgaris α-amylase inhibitor. Br J Nutr 100, 1–12.
4 Goldstein, DJ (1992) Beneficial effects of modest weight loss. Int J Obes Relat Metab Disord 16, 397–415.
5 Pusztai, A, Grant, G, Duguid, T, et al. (1995) Inhibition of starch digestion by α amylase inhibitor reduces the efficiency of utilization of dietary proteins and lipids and retards growth of rats. J Nutr 125, 1554–1562.
6 Boivin, M, Zinsmeister, AR, Brown, ML, et al. (1987) Effect of ileal perfusion of carbohydrates and amylase inhibitor on gastrointestinal hormones and emptying. Mayo Clin Proc 62, 249–255.
7 Fantini, M, Cabras, C, Lobina, C, et al. (2009) Reducing effect of a Phaseolus vulgaris dry extract on food intake, body weight, and glycemia in rats. J Agric Food Chem 57, 9316–9323.
8 Moher, D, Schulz, KF & Altman, DG (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357, 1191–1194.
9 Altman, DG, Schulz, KF, Moher, D, et al. (2001) The revised CONSORT statement for reporting randomised trials: explanation and elaboration. Ann Intern Med 134, 663–694.
10 Review Manager (RevMan) [Computer Program] (2008) .
11 Koike, T, Koizumi, Y, Tang, L, et al. (2005) The anti-obesity effect and the safety of taking “Phaseolamin™ 1600 diet”. J New Rem Clin 54, 1–16.
12 Opala, T, Rzymski, P, Wilczak, M, et al. (2006) Efficacy of 12 weeks supplementation of a botanical extract-based weight loss formula on body weight, composition and blood chemistry in healthy, overweight subjects: a randomized double-blind placebo-controlled clinical trial. Eur J Med Res 11, 343–350.
13 Thom, E (2000) A randomised, double-blind, placebo-controlled trial of a new weight-reducing agent of natural origin. J Int Med Res 28, 229–233.
14 Udani, JK, Singh, BB, Barrett, ML, et al. (2009) Lowering the glycemic index of white bread using a white bean extract. Nutr J 8, 52.
15 Birketvedt, GS, Travis, A, Langbakk, B, et al. (2002) Dietary supplementation with bean extract improves lipid profile in overweight and obese subjects. Nutr J 18, 729–733.
16 Celleno, L, Toliani, MV, D'Amore, A, et al. (2007) A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci 4, 45–52.
17 Udani, J & Singh, BB (2007) Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary fractionated white bean extract. Alt Ther 13, 32–83.
18 Birketvedt, GS, Langbakk, B & Florholmen, J (2005) A dietary supplement with bean extract decreases body weight, body fat, waist circumference and blood pressure in overweight and obese subjects. Curr Top Nutraceut Res 3, 137–142.
19 Díaz, EB, Aguirre, CP & Gotteland, MR (2004) Effect of an α-amylase inhibitor on body weight reduction in obese women. Rev Chil Nutr 31, 306–317.
20 Meiss, DE & Ballerini, R, .
21 Udani, J, Hardy, M & Madsen, DC (2004) Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2TM brand proprietary fractionated white bean extract. Altern Med Rev 9, 63–69.
22 Christian, JG, Tsai, AG & Bessesen, DH (2010) Interpreting weight losses from lifestyle modification trials: using categorical data. Int J Obes 34, 207–209.
23 Wittes, J (2002) Sample size calculations for randomized controlled trials. Epidemiol Rev 24, 39–53.
24 Wadden, TA, Butryn, ML & Wilson, C (2007) Lifestyle modification for the management of obesity. Gastroentorology 133, 2226–2238.
25 Ioannidis, JPA, Evans, SJW, Gøstzsche, PC, et al. (2004) Better reporting of harms in randomized trials. Ann Int Med 141, 781–788.